Back to Archived Journals » Hypoxia » Volume 5

Original Research

KEMTUB012-NI2, a novel potent tubulysin analog that selectively targets hypoxic cancer cells and is potentiated by cytochrome p450 reductase downregulation

       
Total article views   HTML views PDF downloads Totals
8,448 Dovepress* 8,141+ 798 8,939
PubMed Central* 307 104 411
Totals 8,448 902 9,350
*Since 23 May 2017

View citations on PubMed Central and Google Scholar